Analysis

COVID-19 A data perspective

COVID-19: A data perspective: Explore key economic trends and social challenges that arise as the COVID-19 situation evolves.

Filter results by

Search Help
Currently selected filters that can be removed

Keyword(s)

Year of publication

1 facets displayed. 0 facets selected.

Author(s)

2 facets displayed. 1 facets selected.

Survey or statistical program

1 facets displayed. 1 facets selected.
Sort Help
entries

Results

All (1)

All (1) ((1 result))

  • Articles and reports: 88-003-X20000035772
    Geography: Canada
    Description:

    Technological change and innovations depend greatly on R&D activities and investments. R&D is concentrated around the "core firms" that are responsible for 87% of expenditures. Biotechnology R&D performers accounted for $904 million of R&D expenditure. Biotechnology R&D is concentrated in large firms with 75% of R&D occuring in firms with 100 or more employees. Almost 77% of funding sources for R&D in biotechnology came from the private sector and 21% from foreign sources.

    Release date: 2000-10-06
Stats in brief (0)

Stats in brief (0) (0 results)

No content available at this time.

Articles and reports (1)

Articles and reports (1) ((1 result))

  • Articles and reports: 88-003-X20000035772
    Geography: Canada
    Description:

    Technological change and innovations depend greatly on R&D activities and investments. R&D is concentrated around the "core firms" that are responsible for 87% of expenditures. Biotechnology R&D performers accounted for $904 million of R&D expenditure. Biotechnology R&D is concentrated in large firms with 75% of R&D occuring in firms with 100 or more employees. Almost 77% of funding sources for R&D in biotechnology came from the private sector and 21% from foreign sources.

    Release date: 2000-10-06
Journals and periodicals (0)

Journals and periodicals (0) (0 results)

No content available at this time.

Date modified: